Observational Study to Understand Disease Progression in Children and Adults with Stargardt-type Macular Dystrophies

What this Trial Is About

Researchers are studying Stargardt-type macular dystrophies, a group of inherited eye conditions that affect the macula, the central part of the retina responsible for detailed vision. This study aims to learn how the disease progresses in people with Stargardt disease STGD and similar macular dystrophies caused by different genes. The study includes children over 6 years old and adults with these conditions and focuses on comparing disease progression patterns over time. Participants will continue their usual care with their doctors while attending study visits every 6 months for up to 24 months. During these visits, they will undergo standard eye tests and imaging to monitor their vision and retinal health. Medical records and imaging data from the previous 24 months may also be reviewed if available. The study does not involve any investigational treatment but collects detailed information on participants eye health and disease status. Throughout the study, participants will complete various assessments including visual acuity tests and retinal imaging. Researchers will measure changes in best corrected visual acuity BCVA and other vision-related outcomes at regular intervals. Additional data on participants wellbeing, general health, medications, and daily activities will be collected. The study aims to provide a better understanding of disease progression in Stargardt-type macular dystrophies over two years.

A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults